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Objective: The relationship between residual brain tissue in patients with disorders of consciousness (DOC) and the
clinical condition is unclear. This observational study aimed to quantify gray (GM) and white matter (WM) atrophy in
states of (altered) consciousness.
Methods: Structural T1-weighted magnetic resonance images were processed for 102 severely brain-injured and 52
healthy subjects. Regional brain volume was quantified for 158 (sub)cortical regions using Freesurfer. The relationship
between regional brain volume and clinical characteristics of patients with DOC and conscious brain-injured patients
was assessed using a linear mixed-effects model. Classification of patients with unresponsive wakefulness syndrome
(UWS) and minimally conscious state (MCS) using regional volumetric information was performed and compared to
classification using cerebral glucose uptake from fluorodeoxyglucose positron emission tomography. For validation,
the T1-based classifier was tested on independent datasets.
Results: Patients were characterized by smaller regional brain volumes than healthy subjects. Atrophy occurred faster in
UWS compared to MCS (GM) and conscious (GM and WM) patients. Classification was successful (misclassification with
leave-one-out cross-validation between 2% and 13%) and generalized to the independent data set with an area under the
receiver operator curve of 79% (95% confidence interval [CI; 67–91.5]) for GM and 70% (95% CI [55.6–85.4]) for WM.
Interpretation: Brain volumetry at the single-subject level reveals that regions in the default mode network and sub-
cortical gray matter regions, as well as white matter regions involved in long range connectivity, are most important
to distinguish levels of consciousness. Our findings suggest that changes of brain structure provide information in
addition to the assessment of functional neuroimaging and thus should be evaluated as well.
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After severe brain damage, postcomatose survivorsmight suffer from prolonged disorders of conscious-
ness (DOC). Deficits attributed to brain damage are
assessed during clinical examination,1 for which standard-
ized behavioral assessment is still the most sensitive and
reliable tool.2 To this end, clinicians use behavioral scales,
preferably the Coma Recovery Scale-Revised (CRS-R3),
administered several times.4 Patients with unresponsive
wakefulness syndrome (UWS) are fully unaware of them-
selves and their environment.5 Patients in the minimally
conscious state (MCS) show behavioral signs of con-
sciousness in a fluctuating manner, which makes them
difficult to detect even for experienced clinicians.6 Pa-
tients who recover the ability to functionally use objects
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or communicate have emerged from the minimally con-
scious state (EMCS)6 and are no longer considered in a
DOC. Locked-in syndrome (LIS) patients suffer from
apraxia and quadriplegia, limiting their motor function
and causing misdiagnosis even though they are fully con-
scious.7 The diagnostic process, that is, the assessment of
the level of consciousness depending on behavioral obser-
vation, is inherently affected by a certain level of uncer-
tainty beyond control of the clinician attributed to, for
instance, the patient’s sensory and motor disabilities.8
This study aims to identify objective measures derived
from conventional magnetic resonance imaging (MRI),
which is widely available, and thus may increase the
understanding of the relationship between brain structure
and consciousness to guide future diagnostic assessment.
To date, the most sensitive neuroimaging technique to
detect brain function related to residual consciousness is
positron emission tomography (PET) to measure cerebral
glucose uptake.9 Consistency between the clinical and
PET-based diagnosis is present in 85% of the cases.9,10
Conventional T1-weighted MRI is often evaluated
by neuroradiologists or used for the analysis of other
MRI sequences such as functional MRI. However, the
literature regarding the use of T1-weighted MRI in
chronic DOC patients is rather limited. Damage in the
thalamus and in the basal ganglia have been related to
awareness and wakefulness respectively.11 A voxel-based
morphometry study, in which every subject’s brain is nor-
malized to a template and atrophy is quantified voxel-
wise, indicates possible gray matter (GM) differences
between MCS and UWS patient groups.12 These studies
emphasize the potential profit of conventional MRI for
objective assessment of DOC patients, but indicate some
limitations, for example, that the parcellation procedures
are not automated, the data are aggregated on the group
level, or they focus exclusively on subcortical regions.
To improve understanding of the anatomical patho-
physiology and the resulting DOC, we aimed at exploring
GM and white matter (WM) volumetry at a single-subject
level. The fully automated approach adopted here considers
all GM and WM and can be performed on individual sub-
jects even with small brain deformations. Because the uti-
lized methods rely on the single subject’s anatomy rather
than on normalization approaches, which are problematic
in cases of severe brain damage due to underestimation of
the lesion volume,13 a region of interest (ROI) based analy-
sis is conducted instead of a voxel-based one. Clinical
assessment of consciousness was done with repeated assess-
ments of the CRS-R3 and was related to the regional vol-
ume of 84 GM and 74 WM cortical and subcortical
regions in patients, that is, UWS (n5 30), MCS (n5 49),
as well as conscious brain-injured patients (n5 23
including EMCS [n5 19] and LIS [n5 4]) and a group
of healthy subjects (n5 52). In this study, we (1) tested
whether regional volume differs across groups, (2) described
the influence of disease duration and other variables (ie,
age, sex, time since onset, and etiology) on brain volume at
the group-level, (3) assessed the possibility to discriminate
UWS and MCS patients using GM and WM regional vol-
ume, and compared the classification performance to the
PET-based diagnosis, (4) identified the regions with highest
discriminatory power between UWS and MCS patients,
and (5) evaluated the reproducibility of the classifier’s per-
formance on independent patient data sets of collaborating
centers to quantify the generalizability of the classifier.
Patients and Methods
Population
MRI data of 290 patients (Fig 1A) and 52 healthy subjects were
acquired from November 2009 until January 2017 at the Univer-
sity Hospital of Lie`ge, Belgium. For the independent data sets,
we included 38 patients and 15 healthy subjects scanned at the
Neuroradiology Department of the Paris Pitie Salpe^tire`re
(France), and 42 patients and 28 healthy subjects scanned at the
Christian Doppler Klinik in Salzburg (Austria). Even though the
source of brain damage is often obvious when performing quality
checks during the image analysis procedure, the investigators
were blinded to the patient’s diagnosis. Patients were included if
they presented one of the following clinical entities after a period
of coma: UWS, MCS, EMCS, or LIS. Because both EMCS and
LIS patients are not considered to suffer from DOC, these
patients were grouped in one group (conscious). Patients were
excluded for being underage, in an acute stage after brain injury
(ie, scanned< 28 days post-injury), ambiguous clinical diagnosis,
having metal implants not compatible with MRI scanning, and
presenting brain lesions affecting more than two thirds of one
hemisphere. Etiology was categorized as traumatic brain injury
(TBI), or nontraumatic brain injury (ie, anoxia, anoxia plus TBI,
metabolic cause, infection, and hemorrhage). For the Lie`ge data
set, the diagnosis was determined by multiple evaluations (four
to seven) of the CRS-R3 (and additional neuropsychological test-
ing for EMCS and LIS patients) within a week of the MRI scan.
For the Paris and Salzburg data set, patients were assessed at least
twice with the CRS-R. The patient’s outcome was assessed 6
months after hospitalization using the extended version of the
Glasgow Outcome Scale (GOS-E) outcome scale.14 This scale is
the most common outcome measure after brain injury with out-
comes ranging from severe disability (unconscious) to good
recovery and independency. Even if the scale was initially devel-
oped for patients after a TBI, it is used for patients with any
kind of brain injury.9 Healthy subjects and legal guardians of
patients have given their written informed consent according to
the Declaration of Helsinki. The study was approved by the
ethics committee of the University Hospital of Lie`ge. The
Strengthening the Reporting of Observational Studies in Epide-
miology (STROBE) guidelines were followed thoroughly.15
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Data Acquisition
For the Lie`ge data set, structural MRI data were acquired using
a 3 Tesla (T) scanner (Siemens Tim Trio; Siemens Medical Sol-
utions, Erlangen, Germany) with 120T1-weighted slices (repe-
tition time [TR]5 2,300 ms, echo time [TE]5 2.47 ms, flip
angle 9 degrees, voxel size5 13 13 1.2mm3, field of view
[FOV]5 256mm2). Data from sedated and nonsedated
patients are included given the nature of the study. Fluorodeox-
yglucose (18F-FDG) PET were acquired on a Gemini TF PET-
CT scanner (Philips Medical Systems, Best, The Netherlands)
for 86 patients of the Lie`ge data set.
The Salzburg data set was acquired on the same scanner
as the Lie`ge data (TR5 2,300 ms, TE5 2.91 ms, flip angle 9
degrees, voxel size5 13 13 1.2mm3, FOV5 256mm2). The
Paris data set was acquired on a 3T scanner (Signa HDxt GE
Medical Systems; GE Healthcare, Little Chalfont, UK) using
different protocols (12 scans with: TR5 7,636 ms, TE5 3.18
ms, flip angle, 15 degrees, voxel size5 0.493 0.493 1.2mm3,
FOV5 256mm2; 12 scans with the same parameters except the
TR5 716 and the TE5 3.096; one scan with TR5 9,492 ms,
TE5 3.672 ms, flip angle 15 degrees, voxel size5 0.493
0.493 1.4mm3, FOV5 256mm2; one scan with TR5 1,800
ms, TE5 2.35 ms, flip angle 15 degrees, voxel size5 0.423
0.423 0.85mm3, FOV5 256mm2; one scan with TR5 918
ms, TE5 3.584 ms, flip angle 15 degrees, voxel size5 0.493
0.493 0.69mm3, FOV5 256mm2).
Data Processing
Tissue segmentation and (sub)cortical reconstruction were per-
formed using the image analysis software Freesurfer (version
5.3.0). In short, we normalized scan intensity artifacts,16 re-
moved nonbrain tissue, applied an automated Talairach trans-
formation, segmented subcortical WM and GM,17 tessellated
the GM-WM boundary,18 and placed tissue boundaries on vox-
els with the biggest intensity shift.19 The individuals’ cortical
model was registered to a spherical atlas based on cortical fold-
ing patterns, in order to match the cortical geometry.20 The
cortical surface was then parcellated based on the individuals’
gyri and sulci pattern using the Desikan Killiany atlas.15 The
accuracy of skull stripping, segmentation, and cortical recon-
struction was visually inspected for each subject, and in case of
inaccuracies during any of these steps, the subject was excluded.
An example of the resulting segmentation for a patient from
each diagnosis can be found in Figure 1B.
Regional volumes were normalized using the (estimated)
total intracranial volume (ICV) as presented elsewhere,21,22
which has been validated against manual segmentation of
ICV.22 Separate group mean ICV were used for the healthy
and patient samples from each acquisition site. A total of 84
cortical and subcortical GM regions and 74 WM regions were
selected for further analysis (for description of the regions, see
a previous work23). When required by the linear model
assumptions, the logarithm of the volume in cm3 was
considered.
PET data were analyzed as described elsewhere.9
Statistical Analysis
Statistical analysis was performed using R software (R Founda-
tion for Statistical Computing, Vienna, Austria).24 v2 tests were
used to evaluate differences in distribution of sex in the patient
groups and healthy subjects, and differences in the distribution
of etiology within the patient groups. Equality of mean age
within the patient groups and healthy subjects was assessed
FIGURE 1: (A) Flowchart and inclusion criteria. Data in this
study were collected using stringent inclusion criteria on the
MRI quality and brain injury. Of the 290 adult and nonacute
(ie,>28 days postinjury), 102 could be included in the study and
86 patients had a PET available. (B) Freesurfer segmentation for
a representative subject of each patient sample. Shown are
four axial T1-weighted slices, with labeled parcellated gray mat-
ter, subcortical structures, and white matter according to the
Desikan-Killiany atlas. UWS5unresponsive wakefulness syn-
drome; MCS5minimally conscious state; Conscious5 repre-
sented by patients in LIS (Locked-in syndrome) and EMCS
(emergence fromminimally conscious state).
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with a Welch two-sample t test. An analysis of variance
(ANOVA) model was utilized to evaluate whether mean days
between the onset and scan time were equal within each patient
group. We tested for evidence of a hemispheric laterality effect
on GM and WM volume using a two-way ANOVA with diag-
nosis, hemispheric laterality, and the interaction between the
two as covariates. Given the results of our test on hemispheric
laterality, left and right hemispheric analogous volumes were
averaged. To test for equality of regional volume sizes between
the two scanners, we used a Welch two sample t test on the
healthy subjects from the three centers.
We tested for group differences in regional GM and WM
volume between healthy and brain-injured subjects using multi-
variate analysis of covariance with sex and age as covariates. Pil-
lai’s trace statistics were used to test the significance of the
covariates on overall regional volumes. The group differences in
individual regional volume are reported by their group mean
and 95% simultaneous confidence intervals (CIs), which were
Bonferroni corrected (a for GM: 1–0.05/425 0.998; WM: 1–
0.05/405 0.998).
A linear mixed-effects model (R package: lme4) was uti-
lized to assess the effect of different demographic features on
GM and WM atrophy within the patient population. In partic-
ular, we model the logarithm* of the volume in cm3. Fixed-
effects terms were included for sex, etiology, age, diagnosis, and
years since onset, and the interactions between the latter two.
We included random intercepts to model subject and regional
effects, together with a random slope for the years since onset.
Because the regional volumes appear more volatile for small val-
ues of the days since onset, we modeled the variance of the
regression errors as proportional to the inverse of the value of
the covariate. This allows to avoid heteroscedasticity effects.
The following equation describes the linear regression model
(the column symbol indicates variable interaction):
logðYijÞ5b01b1YearsOnsetij1b2Diagnosisij
1b3YearsOnsetij : Diagnosisij1 b4Ageij1 b5Etiologyij
1b6Genderij1v0j1 b0i1 b1iYearsOnsetij1 eij
eij  N ð0; r2eXÞ;with X5diagð1=YearsOnsetijÞ
v0j  N ð0; s20Þ; bki  N ð0;w2kÞ; Covðbki; bk0iÞ5wkk0
where logðYijÞ is the volume of the i th brain region (with
i51; . . . ;M ) observed for the j th subject (with j51; . . . ; ni),
bp for p50; . . . ; 6 are the fixed-effect coefficients (0 indicates
the intercept), v0j and b0i indicate the random intercepts for
subject and region, respectively, and b1i indicates the random
slope. Please note that we do not make any assumptions about
the structure of the random effects variance-covariance matrix
except that the effects for region i are independent from the
ones of any other region i0.
The ability of regional volume to discriminate UWS and
MCS patients was assessed through a leave-one-out boosting
classification trees procedure (adaboost25). The boosting classi-
fiers were built by using 100 stumps (ie, minimal classification
trees with two terminal nodes). This method performs an
intrinsic (soft) feature selection by providing a measure of
regional importance alongside the classification task. The pre-
diction accuracy for new cases was evaluated using a bootstrap
leave-one-out cross-validation procedure. This method does not
rely on any distributional assumption and achieves accurate
error estimation in small samples,26 thus making it an appropri-
ate tool for our study (because we have only 49 MCS and 30
UWS patients). We generated 500 bootstrap samples with at
least 3 UWS and 3 MCS patients.
The relevance of each regional brain volume (feature) was
assessed by looking at the (average) classifier’s importance
parameter computed for each region (as formulated in a previ-
ous work25). This parameter identifies the influence on the clas-
sification task of a single feature as compared to the others. If
all the regions would have the same relevance, the importance
would be equal to 2.33% (100 divided by 43 ROIs) for GM
and 2.63% (100 divided by 38 ROIs) for WM. For each sub-
ject, the classification probabilities were saved and used to select
the most advantageous probability threshold.
To evaluate the diagnostic ability of the binary classifier,
we produced receiver operating characteristic (ROC) curves
that display the classifiers’ sensitivity and specificity for various
discrimination thresholds. The area under the ROC curve
(AUROC), a measure varying between 0 and 1 with 0.5 reflect-
ing a no-information rate, can be interpreted as the percentage
of correctly classified randomly drawn pairs with 1 subject from
the UWS and MCS groups. Additionally, the results are com-
pared to the diagnosis as established with PET, the neuroimag-
ing technique with highest diagnostic precision.9 Subjects from
the test data were classified by the same adaboost procedure
with 100 iterations, using the probability threshold set as in the
training data set. Differences in sex and etiology between the
test and training data sets were assessed with a v2 test, and dif-
ference in mean age and year since onset were assessed with a
Welch two sample t test.
Results
Of the 290 patients scanned, 156 met the inclusion crite-
ria (Fig 1A) of the study for which segmentation of T1
MRI was attempted. The final sample consists of 102
patients (23 conscious [ie, 4 LIS, 19 EMCS]), 49 MCS,
and 30 UWS). GOS-E outcomes14 and subject-specific
information are reported in Supplementary Table 1.
Fifty-four patients were excluded because of failure dur-
ing the segmentation procedure (either the software
could not come to a solution, or the software excluded
brain tissue; see Supplementary Table 2 for detailed
information per subject). No group differences between
patient groups have been observed for etiology and mean
years since onset (Table and Supplementary Table 3).
*Please note that the estimated regression parameters of the log-linear
model can be interpreted as percentage changes for small values of the ith
coefficient, (exp(bi) 11bi).
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The 52 healthy subjects did not differ from the patients
in sex or mean age (Table and Supplementary Table 4).
The PET protocol was completed for 21 conscious
patients (20 with a PET diagnosis of MCS and 1 of
UWS), 45 MCS patients (40 with a PET diagnosis of
MCS and 5 of UWS), and 22 UWS patients (6 with a
PET diagnosis of MCS and 16 of UWS).
No effect of hemispheric laterality or an interaction
between clinical state and hemispheric laterality was
observed on GM or WM volume (Supplementary Table
5). Therefore, subsequent analysis was conducted on the
average regional volumes of the left and right hemi-
sphere. We did not find evidence for a difference in
mean regional GM (t(864.96)5 1.941, p5 0.053, 95%
CI [20.001, 0.114]) and WM (t(822.02)5 0.444,
p5 0.657, 95% CI [2326.8, 517.7]) volume within
healthy subjects between the two different scanners.
Healthy Subjects Versus Brain-Injured Patients
Overall regional volume in brain-injured patients (con-
scious patients, MCS, and UWS) was reduced in GM
and WM compared to the healthy population, and age
but not sex negatively affects GM and WM volume (for
Pillai statistics, see Supplementary Table 6). Looking at
the difference between healthy and brain-injured subjects
at the single-region level, evidence for a difference exists
in all GM ROIs, except the frontal and temporal pole
(Fig 2A). For the WM, there is a difference in the whole
corpus callosum (ie, anterior, mid-anterior, central, mid-
posterior, and posterior parts), the pre- and postcentral
areas, the caudal middle frontal, pars opercularis, the
para-hippocampus, the pericalcarine, the fusiform, and
lingual areas (Fig 2B).
Effect of Demographic Factors on Atrophy
Within Brain-Injured Patients
We found evidence of a bigger regional brain volume in
conscious patients compared to UWS patients in both GM
and WM. WM volume is higher for male than for female
patients. Our results highlight that a longer time postinjury
(in years) is related to smaller regional volumes, regardless
of diagnosis. The model estimates of the fixed effects, con-
fidence intervals, and significance levels can be found in
Figure 3A for the GM and Figure 3B for the WM analy-
sis. In addition, we found a significant interaction effect
between diagnosis and time since onset, revealing that
unconscious UWS patients lose brain matter faster than
MCS (GM) and conscious (GM and WM) patients (see
Fig 3C,D for GM and WM analysis, respectively).
Classifying MCS and UWS Patients
Classification of DOC patients (UWS and MCS) with
leave-one-out cross-validation on the T1-based GM
measures had an AUROC of 96% (95% CI [92.4–
99.6]), with a sensitivity of 0.92 (95% CI [0.82, 0.98])
and a specificity of 0.84 (95% CI [0.69, 0.95]). For the
WM-based classification, we obtained an AUROC of
97.6% (95% CI [94.8–100]), with a sensitivity of 0.90
(95% CI [0.81, 0.97]), and a specificity of 0.96 (95%
CI [0.83, 1.00]; Fig 4). This is comparable to the
results of the classification based on PET glucose
uptake, for which we found a sensitivity of 0.89 (95%
TABLE 1. Group Means (and Standard Deviation If Applicable) for Age, Sex, Etiology, and Years Since Onset
for Healthy Subjects and Patients From Lie`ge and the Independent Centers (Paris and Salzburg)









Healthy Lie`ge, n5 52 NA 39.9(16.1) 25/21/6 NA NA
Healthy independent
centers, n5 43
NA 44.1(13.0) 18/25/0 NA NA
Patient Lie`ge, n5102 UWS, n5 30 48.1(16.5) 20/10/0 16,1,11,2 1.9(4.1)
MCS, n5 49 36.7(13.0) 33/16/0 11,6,27,5 2.8(3.1)
Conscious, n5 23 39.3(15.1) 16/7/0 9,0,13,1 3.4(5.3)
Patient independent
centers, n5 55
UWS, n5 27 42.6(15.1) 19/8/0 17,1,4,4 0.5(1.0)
MCS, n5 28 45.4(15.3) 20/8/0 10,0,6,11 0.7(1.4)
TBI5 traumatic brain injury; Mix5TBI1 anoxia.
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CI [0.78, 0.96]) and a specificity of 0.73 (95% CI
[0.53, 0.89]).
When comparing the neuroimaging diagnosis (T1
and PET) to the CRS-R diagnosis, we used only the best
result of either neuroimaging modality (eg, if a patient is
clinically MCS and either one of the neuroimaging diag-
nosis is MCS, it is considered a correct classification, but
if a patient is clinically diagnosed as UWS and either one
of the neuroimaging diagnosis is MCS, it is considered a
false positive). There was a congruence between the CRS-
R and neuroimaging for the GM in 64% of the UWS
patients and 98% of the MCS patients, and for the WM
in 41% of the UWS and 96% of the MCS patients (Sup-
plementary Table 7). In only 1 and 2 MCS patients (for
GM and WM, respectively), neither the T1 nor PET-
based diagnosis was able to detect objective markers for
consciousness while behavioral signs of MCS were
observed. In 36% and 59% of the clinically diagnosed
UWS patients, the T1 (for GM and WM, respectively)
and/or PETwere indicative for a state of MCS.
Our results furthermore show highly relevant
regions for classification of UWS and MCS patients
(importance level of roughly 2 times the chance level; Fig
5A,B for GM and WM, respectively). In particular, we
found that the GM volume of the paracentral (7.34%),
para-hippocampal (7.10%), thalamus (4.73%), caudate
(4.50%), inferior parietal (4.14%), entorhinal (4.03%),
and medial orbitofrontal (4.00%) cortex were key fea-
tures in discriminating between patient groups. The most
influencing WM regions include the rostral anterior cin-
gulate (8.51%), banks of the superior temporal sulcus
(7.85%), anterior part of the corpus callosum (6.60%),
brain stem (6.45%), isthmus cingulate (6.29%), pars tri-
angularis (6.09%), caudal anterior cingulate (5.89%),
medial orbitofrontal (5.63%), para-hippocampal
(5.35%), and inferior temporal (4.26%).
To quantify the generalizability of the proposed
classifier, we classified an independent test data set from
two different centers. Preprocessing was successful for 27
out of 38 patients from Paris, and 28 out of 42 patients
from Salzburg. In total, 27 MCS and 28 UWS patients
have been included in the classification protocol (Sup-
plementary Table 1 for subject-specific demographic
information, Supplementary Table 2 for subject-specific
information of subjects where preprocessing failed). No
difference in sex and age was found between the training
FIGURE 2: Estimates and Bonferroni corrected 95% confidence interval for regional gray (A) and white (B) matter region size
for patients and healthy subjects.
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and test data (Table and Supplementary Table 4). Signifi-
cant differences between the two data sets were found for
time since onset and etiology (Table and Supplementary
Table 3). For the GM classification, we obtained an
AUROC of 79.2% (95% CI [67–91.5]), with a sensitiv-
ity of 0.85 (95% CI [0.69, 0.95]) and a specificity of
0.71 (95% CI [0.54, 0.87]). The WM classification is
slightly less successful (AUROC 70.5%; 95% CI [55.6–
85.4]), with a sensitivity of 0.77 (95% CI [0.61, 0.93])
and a specificity of 0.62 (95% CI [0.45, 0.80]; Fig 6).
This led to a correct classification of 23 of 27 MCS
patients and 20 of 28 UWS patients using GM volume.
Using WM regions, we obtained a correct classification
for 21 of 27 MCS patients and 17 of 27 UWS patients
(Supplementary Table 8).
Discussion
In this study, we aimed at quantifying regional cortical
and subcortical brain atrophy in severely brain-injured
patients using a fully automated whole-brain segmenta-
tion method. As expected, brain-injured patients have
reduced regional volume compared to healthy subjects in
almost all brain regions. A handful of the smallest brain
regions did not show any difference, possibly attributed
to the limited absolute atrophy because of their small
size. Our sample including healthy subjects also demon-
strated a decrease in regional size with increasing age, as
documented in the literature.27
Next, we assessed the impact of the patient’s demo-
graphic characteristics on regional brain volume. Regard-
less of the patients’ clinical presentation, increased time
FIGURE 3: (A,C) Estimates and standard deviations of the fixed effects for the linear mixed-effects model on regional volumes,
in gray (A) and white (B) matter respectively. Please note that the presented regression parameters of the log-linear model can
be interpreted as expected percentage change (because expðbÞ  11b for small b). For example, on average, GM ROIs within
the MCS patient group are 5% bigger than in UWS patients (because exp (0.05)51.051). MCS and conscious patients are com-
pared to UWS patients. Sex presents how males differ from females, and for etiology is presented how TBI patients differ
from non-TBI (eg, anoxia, hemorrhage). Time since onset (referred to as time) and age should be interpreted as the regional
volume change per year. *p<0.05; **p<0.01; ***p<0.001. (B,D) Estimated mean regional volume decrease (and 95% confi-
dence interval) with increasing years since onset for each patient group in gray (C) and white (D) matter. UWS5unresponsive
wakefulness syndrome, MCS5minimally conscious state, Conscious5 represented by patients in LIS (Locked-in syndrome) and
EMCS (emergence from minimally conscious state).
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since brain injury negatively affected regional GM and
WM volume. Nonetheless, unconscious patients show
more severe atrophy over time when compared to
patients with some level of residual consciousness (in
GM for MCS, in WM and GM for conscious patients).
These results highlight the fact that patients sustaining
FIGURE 4: ROC curves show the trade-off between sensitiv-
ity and specificity for the leave-one-out bootstrap cross-
validation for the classification of UWS and MCS patients
based on grey and white matter regional volumes.
GM5gray matter; WM5white matter.
FIGURE 5: Gray (A) and white (B) matter regional importance for the classification of UWS and MCS patients. This parameter
identifies the influence of a single feature on the classification result as compared to the other features as presented by the
weight of the stump. Only regions with classification importance higher than chance (2.33% for gray matter and 2.66% for
white matter) are displayed in color according to their importance. MCS5minimally conscious state, UWS5unresponsive
wakefulness syndrome.
FIGURE 6: ROC curves present the trade-off between sensi-
tivity and specificity for the classification of UWS and MCS
patients from the independent test data sets (ie, Salzburg
and Paris) using grey and white matter regional volumes.
GM5grey matter, WM5white matter.
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awareness are more likely to preserve a larger brain vol-
ume over time, whereas unconscious patients are prone
to substantial GM and WM loss. Our results in brain-
injured patients are in agreement with those of Rubeaux
and colleagues,28 who observed a slower atrophy of the
thalamus in MCS patients than in UWS patients. Main-
tenance of brain volume is also associated with a better
prognosis in the acute phase of brain injury.29 This sug-
gests a “use it or lose it” principle in which activated
neurons seem to better withstand neurodegeneration and
atrophy, as observed in Alzheimer’s disease as well.30 Two
famous postmortem case studies in persistent UWS
patients support our finding of more severe atrophy with
increasing time postinjury. Karen Ann Quinlan’s brain
weighed 66% (835g) of the normal 1.3kg after 10 years
of UWS,31 whereas Terri Schiavo’s brain showed more
atrophy and weighed only 47% (615g) after 15 years of
UWS. Similar autopsy studies of MCS patients to con-
firm our findings are lacking, however.
We did not observe a difference in mean regional
volume between UWS and MCS patients, though previ-
ous findings suggest that regional differences exist.12
Indeed, we identified regional relevance to discriminate
conscious and unconscious brains with above-chance-
level accuracy. This suggests that specific brain areas’,
rather than the brain in general, structural integrity is
important for consciousness. A congruence between the
T1-based classification and the CRS-R diagnosis of at
least 87% was found, emphasizing the validity of our
results. This exceeds previously published PET-based clas-
sification accuracies, that is, 83% using cortical variance
in glucose uptake,10 85% obtained with a similar proc-
essing approach as adopted in this article,9 as well as
87% using metabolism of the best preserved hemi-
sphere.32 When the T1- and PET-based diagnosis are
combined, we find a false-negative rate of 2% and 4%
for GM and WM, respectively, suggesting that combin-
ing different modalities is a powerful tool to detect resid-
ual consciousness. When considering both techniques,
the false-positive rate increases, especially in UWS
patients. However, these patients (also referred to as
MCS* patients) might not show behavioral signs of con-
sciousness, yet results of paraclinical assessments (such as
neuroimaging and neurophysiology) are indicative for the
presence of residual consciousness.33 In clinical practice it
is important to identify these patients because the diag-
nosis has significant implications for clinical manage-
ment, treatment, and prognosis.34,35
Good classification accuracy was observed for the
test data, with an AUROC of 79% (95% CI [67-91.5])
for GM and 70% (95% CI [55.6-85.4]) for WM. These
performances were achieved despite differences in
etiology and time post-injury (which are known to have
divergent effects on structural integrity12,36), number of
behavioral assessments (which could influence the final
diagnosis of DOC patients4), and MRI scanners (which
might influence the preprocessing, even if Freesurfer is
relatively stable across different MRI scanners37,38). This
demonstrates the potential of the proposed method in
different clinical settings.
From our analysis, it appears that the most infor-
mative GM regions include the (para-) hippocampal area
and entorhinal cortex. These regions are important for
the formation of episodic memory, permit rapid process-
ing enabling contextualization of events in the world,
and are well located to bind associations from other cor-
tical streams, suggesting a key function for conscious-
ness.39 We have found these regions to be severely
damaged in persistent UWS patients and to a lesser
extend in MCS patients, which is in line with observa-
tions in postmortem studies.40 Other areas that seem to
play a key role in the classification protocol are the thala-
mus and caudate, which are associated to recovery of
motor and cognitive function in the mesocircuit hypoth-
esis.41 The thalamus receives sensory information and
redirects the excitatory input to the (frontal) cortex,
which, in turn, drives neurons in the caudate (part of the
striatum). Generally, the caudate indirectly excites the
thalamus, but without sufficient excitation in the stria-
tum the thalamus is inhibited, which may lead to the
underlying malfunction of this circuit in DOC
patients.41 Atrophy in the thalamus has been correlated
to CRS-R total scores, but could not be related to clini-
cal status directly.11 Our findings provide direct evidence
for a possible relationship between brain structure and
pathological states of consciousness. Last, frontal regions
together with inferior parietal regions and cingulate areas
bear high classification relevance. These regions are all
part of the default mode network (DMN), a complex of
regions believed to have a prominent role in impaired
consciousness. Especially these regions show severe abnor-
malities in glucose metabolism,42 structural WM,43 and
functional connectivity,44,45 that is, linearly related to
consciousness levels in DOC patients. The presented
results suggest that these functional changes may have a
structural basis in GM volume as well.
WM regions with high discriminatory power
include the cingulate area, the (superior) temporal WM,
and the brainstem. The temporal cortex is involved in
auditory processing. Our results are in line with a recent
study indicating that functional connectivity within the
auditory network is the most sensitive compared to other
functional networks to objectively discriminate between
UWS and MCS patients.46 Mostly, WM regions
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important for long-range connectivity are affected in
UWS patients as compared to MCS patients, corroborat-
ing with the notion that loss of consciousness results
from regions functioning in isolation.47 The UWS can
be explained as preserved brainstem function with loss of
cortical function,48 even if islands of preserved function
might exist during unconsciousness.49 Yet, we do
observe differences in brainstem volume for UWS and
MCS patients. This might be attributed to widespread
Wallerian-type degeneration affecting the corticospinal
tracts and hence brainstem volume,50 which might be
more prominent in UWS patients than in MCS patients
who show a broader spectrum of behavior.
Finally, we would like to mention three possible
limitations of this work. First of all, brain atrophy was
not assessed in a longitudinal fashion. This would be
preferable in order to study the dynamics of volumetric
changes on the subject level, and would permit to assess
the influence of the clinical evolution on the misclassifi-
cation rate. Yet, the size of the analyzed sample and the
large number of observations within each subject support
the validity of our findings. Second, even if our approach
does not involve brain function, brain activity depends to
some extent on structural integrity,43 and indeed our
results indicate a congruence with glucose uptake. There-
fore, we believe our results are clinically relevant. Last,
given the nature of the fully automated analysis, we have
only included patients with a relatively preserved brain
and excluded around one third of the patient data from
all three centers. This could bias our results, and appear
as a limitation in clinical practice. However, this bias
exists for all neuroimaging methods. Moreover, we
believe that the current study emphasizes the importance
of structural investigation in addition to functional neu-
roimaging, of which the latter could be difficult to
implement in clinical practice given that functional data
is heavily confounded by sedation and motion.
To summarize, we evaluated regional GM and WM
differences in healthy subjects and patients, showing that
brain-injured patients have decreased regional volumes
compared to healthy subjects. Within the patient sample,
we tested for group differences and have found dimin-
ished regional volume in UWS compared to conscious
patients. Moreover, there was evidence for a negative
relationship between regional brain volume and disease
duration regardless of diagnosis, whereas atrophy appears
faster in UWS patients than in the MCS (GM) and con-
scious patients (GM and WM). Finally, regional volume
seems to discriminate UWS and MCS patients as well
(internal validation GM-AUROC 96% (95% CI [92.4–
99.6]), WM-AUROC 97.6% (95% CI [94.8–100]);
independent test data GM-AUROC 79.2% (95% CI
[67.0–91.5]), WM-AUROC 70% (95% CI [55.6–
85.4])). The most important GM regions for classi-
fication belong to the DMN and subcortical areas, and
relevant WM areas are important for long-range connec-
tivity. Our findings highlight the importance of regional
brain volume assessments for clinical evaluation of DOC
patients. Therefore, structural MRI quantification should
be considered alongside functional neuroimaging to im-
prove the clinical diagnosis of DOC patients.
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